Search details
1.
An AI-guided screen identifies probucol as an enhancer of mitophagy through modulation of lipid droplets.
PLoS Biol
; 21(3): e3001977, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36862640
2.
Cell-Specific Dysregulation of Iron and Oxygen Homeostasis as a Novel Pathophysiology in PSP.
Ann Neurol
; 93(3): 431-445, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36309960
3.
Prevalence and Distribution of Lewy Pathology in a Homeless Population.
Can J Neurol Sci
; : 1-7, 2023 Oct 05.
Article
in English
| MEDLINE | ID: mdl-37793895
4.
α-Synuclein molecular behavior and nigral proteomic profiling distinguish subtypes of Lewy body disorders.
Acta Neuropathol
; 144(2): 167-185, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35748929
5.
Epigenetic Clock Acceleration Is Linked to Age at Onset of Parkinson's Disease.
Mov Disord
; 37(9): 1831-1840, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35921480
6.
Exposure to Phosphoglycerate Kinase 1 Activators and Incidence of Parkinson's Disease.
Mov Disord
; 36(10): 2419-2425, 2021 10.
Article
in English
| MEDLINE | ID: mdl-34241922
7.
Using artificial intelligence to identify anti-hypertensives as possible disease modifying agents in Parkinson's disease.
Pharmacoepidemiol Drug Saf
; 30(2): 201-209, 2021 02.
Article
in English
| MEDLINE | ID: mdl-33219601
8.
Short-term deceleration capacity of heart rate: a sensitive marker of cardiac autonomic dysfunction in idiopathic Parkinson's disease.
Clin Auton Res
; 31(6): 729-736, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34251546
9.
Regulation of myeloid cell phagocytosis by LRRK2 via WAVE2 complex stabilization is altered in Parkinson's disease.
Proc Natl Acad Sci U S A
; 115(22): E5164-E5173, 2018 05 29.
Article
in English
| MEDLINE | ID: mdl-29760073
10.
Emerging drugs for the treatment of L-DOPA-induced dyskinesia: an update.
Expert Opin Emerg Drugs
; 25(2): 131-144, 2020 06.
Article
in English
| MEDLINE | ID: mdl-32366130
11.
Identifying drugs with disease-modifying potential in Parkinson's disease using artificial intelligence and pharmacoepidemiology.
Pharmacoepidemiol Drug Saf
; 29(8): 864-872, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32410265
12.
Increased markers of cardiac vagal activity in leucine-rich repeat kinase 2-associated Parkinson's disease.
Clin Auton Res
; 29(6): 603-614, 2019 12.
Article
in English
| MEDLINE | ID: mdl-31444591
13.
The MonKEY to Unlocking the Pathogenesis of Progressive Supranuclear Palsy.
Mov Disord
; 38(6): 953-954, 2023 06.
Article
in English
| MEDLINE | ID: mdl-37050873
14.
Clustering of motor and nonmotor traits in leucine-rich repeat kinase 2 G2019S Parkinson's disease nonparkinsonian relatives: A multicenter family study.
Mov Disord
; 33(6): 960-965, 2018 Jul.
Article
in English
| MEDLINE | ID: mdl-29665080
15.
Combining Skin α-Synuclein Real-Time Quaking-Induced Conversion and Circulating Neurofilament Light Chain to Distinguish Multiple System Atrophy and Parkinson's Disease.
Mov Disord
; 37(3): 648-650, 2022 03.
Article
in English
| MEDLINE | ID: mdl-35019153
16.
Heart rate variability in leucine-rich repeat kinase 2-associated Parkinson's disease.
Mov Disord
; 32(4): 610-614, 2017 04.
Article
in English
| MEDLINE | ID: mdl-28071824
17.
Withdrawal: Effect of Ser-129 phosphorylation on interaction of α-synuclein with synaptic and cellular membranes.
J Biol Chem
; 295(39): 13695, 2020 Sep 25.
Article
in English
| MEDLINE | ID: mdl-32978333
18.
Correction: α-Synuclein membrane association is regulated by the Rab3a recycling machinery and presynaptic activity.
J Biol Chem
; 295(41): 14248, 2020 Oct 09.
Article
in English
| MEDLINE | ID: mdl-33037082
19.
Retraction Note to: Differential regulation of wild-type and mutant alpha-synuclein binding to synaptic membranes by cytosolic factors.
BMC Neurosci
; 22(1): 40, 2021 Jun 03.
Article
in English
| MEDLINE | ID: mdl-34082697
20.
Call the Plumber: Impaired Meningeal Lymphatic Drainage in Parkinson's Disease.
Mov Disord
; 36(5): 1125, 2021 05.
Article
in English
| MEDLINE | ID: mdl-33786905